• treefrog@lemm.ee
    link
    fedilink
    arrow-up
    0
    ·
    1 month ago

    Bought is it.

    Mental health meds are a huge industry. MDMA has the potential to help cure what other medication can only treat.

    • hellofriend@lemmy.world
      link
      fedilink
      arrow-up
      0
      ·
      1 month ago

      Nah, that’s not the issue (nor do I believe in magic bullets, but that’s a different matter). See, the issue is that MDMA can’t be patented. Anyone can make it so no one pharmacorp can have a 20 year monopoly

      • Bakkoda@sh.itjust.works
        link
        fedilink
        arrow-up
        0
        ·
        1 month ago

        Usually first to market work generics enjoys a year of exclusivity. Usually other companies abandon our back burnera project they don’t make to market first. There’s still money to be made. Just not as much.

        • AggressivelyPassive@feddit.de
          link
          fedilink
          arrow-up
          0
          ·
          1 month ago

          I think you don’t quite understand the comment.

          Current pharmaceuticals are usually a (life)long prescription. It’s not like antibiotics, where you get a dose for a few days or weeks and you’re done. Antidepressants have to be taken for years. Every day. That means revenue every day. It’s a treatment, not a cure.

          MDMA on the other hand is a (potential) cure. You take it a few times under supervision and that’s it.

          Problem is, this takes away customers from the former group. And that means, far less revenue from “traditional” psychopharmacology products. MDMA cannibalizes other drugs.